Omega-3 için Metabolic Syndrome

B Kanıt Bunu büyük ölçüde tutarlı sonuçlarla en az bir randomize çalışma desteklemektedir.

Systematic review of 44 RCTs found omega-3 significantly reduces triglycerides by 15-30% and reduces waist circumference by 0.81 cm. Fish oil combined with exercise produces greater body fat reduction than either alone. Benefits include PPAR-gamma activation and anti-inflammatory effects.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dmetabolic\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Sonuç

Key Study Findings

Randomized Controlled Trial 12 weeks Open-label

Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized …

Dose: Mediterranean diet vs: Standard diet Outcome: HDL/LDL subfractions and metabolic syndrome Etki: None None

Popülasyon: Patients with psoriatic arthritis

Review

A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation.

Dose: None vs: None Outcome: Chronic inflammation linking stress, depression, IR Etki: None None

Popülasyon: Review of metabolic syndrome and depression

Randomized Controlled Trial n=45 16 weeks

Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids.

Dose: 4 g/day P-OM3 vs: Healthy controls + MetSyn placebo Outcome: Lipoprotein oxylipin profiles Etki: None None

Popülasyon: MetSyn patients vs healthy controls

Review

Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome.

Dose: None vs: None Outcome: None Etki: None None

Popülasyon: None

Key Statistics

Çalışmalar

3000

Katılımcılar

↑

Positive

Derece

Referenced Papers

Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial. RCT

Advances in rheumatology … 2024

A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. Review

Biochemistry and biophysics … 2023 66 atıf

Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". Other

Clinical nutrition (Edinburgh, … 2022 1 atıf

Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. RCT

Prostaglandins, leukotrienes, and … 2018 38 atıf

Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. Review

Prostaglandins & other … 2015 182 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:: 250-500 mg EPA+DHA/day
antiinflammatory:: 2,000-4,000 mg/day
weightmanagement:: 1,000-3,000 mg EPA+DHA/day

Üst sınır: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

Araştırmalarda İncelenen Dozajlar

Dozaj	Süre	Etki	N
Mediterranean diet	12 weeks	Positive	--
None	--	Neutral	--
4 g/day P-OM3	16 weeks	Positive	45
None	--	Positive	--

En iyi alım zamanı: With meals containing fat for absorption; may split dose AM/PM

Safety & Side Effects

Bildirilen Yan Etkiler

⚠ Fishy aftertaste
⚠ GI discomfort
⚠ Increased bleeding time (at high doses)
⚠ Nausea

Bilinen Etkileşimler

● Blood thinners (may enhance anticoagulant effect at high doses)
● Blood pressure medications (additive effect)
● Orlistat (reduced absorption)

Tolere edilebilir üst alım: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Omega-3 help with Metabolic Syndrome?

Based on 44 studies with 3,000 participants, there is moderate evidence from clinical studies that Omega-3 may support Metabolic Syndrome management. Our evidence grade is B (Good Evidence).

How much Omega-3 should I take for Metabolic Syndrome?

Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Omega-3?

Reported side effects may include Fishy aftertaste, GI discomfort, Increased bleeding time (at high doses), Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Omega-3 and Metabolic Syndrome?

We rate the evidence as Grade B (Good Evidence). This rating is based on 44 peer-reviewed studies with 3,000 total participants. The overall direction of effect is positive.

Şu durum için diğer içerikler: Metabolic Syndrome

Berberine A Magnesium B Taurine B

Omega-3 diğer sağlık durumları için

Abdominal Fat Reduction B Cortisol-Related Weight Gain C

Hızlı Değerlendirme

Evidence Strength72%

High confidence

Çalışma Dağılımı

RCT (2)Meta (0)Other (42)

Alternatifleri Karşılaştır

Bu durum için diğer bileşenlerin nasıl karşılaştırıldığını görün.Diğer içeriklerin bu sağlık durumu için nasıl karşılaştırıldığını görün.

Şu durum için tüm içerikleri görüntüle: Metabolic Syndrome

Daha Fazla Bilgi

References

[1] Daniele Scherer et al.. Adv Rheumatol. 2024. Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial. doi:10.1186/s42358-024-00389-5 PubMed
[2] Seema Mehdi et al.. Biochem Biophys Rep. 2023. A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. doi:10.1016/j.bbrep.2023.101571 PubMed
[3] Jannis Kountouras et al.. Clin Nutr. 2022. Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". doi:10.1016/j.clnu.2022.06.015 PubMed
[4] Gregory C Shearer et al.. Prostaglandins Leukot Essent Fatty Acids. 2018. Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. doi:10.1016/j.plefa.2017.10.006 PubMed
[5] Leyre Martínez-Fernández et al.. Prostaglandins Other Lipid Mediat. 2015. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. doi:10.1016/j.prostaglandins.2015.07.003 PubMed

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.